CLINICAL_TRIALS
trial_result
· 2026-02-04
Clinical Trial Update: Lemborexant Shift Work Treatment Study [Phase 4]
Summary
A Phase 4 study evaluating lemborexant for shift work sleep disorder has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Shift-Work Related Sleep Disturbance | Phase 4 | Status: COMPLETED | Results posted: 2026-02-04